Keith Muir

MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom.

Edinburgh Technology Fund Ltd ( Edinburgh Technology ) is a venture capital firm founded in 1999. The firm is headquartered in Edinburgh.

Old College Capital (Old College Capital LP) is a venture capital division of the University of Edinburgh, founded in 2011. The firm is headquartered in Scotland.

Manchester Imaging Ltd. develops dental diagnostic software solutions. It operates as a platform technology underpinning an image analysis software portfolio with development applications in several aspects of dental healthcare. The company was founded by Jim Graham and Hugh Devlin and is headquartered in Manchester, the United Kingdom.

Invizius Ltd. develops application for dialysis patients. It offers hemo compatibility for dialyzers. The company was founded by Andrew Herbert on January 26, 2018 and is headquartered in Edinburgh, the United Kingdom.

In-Part Publishing Ltd. operates a matchmaking platform for university-industry collaboration. It connects businesses with academics looking for university-industry collaboration, technology transfer and research commercialization partnerships. The company was founded by Patrick Speedie and Robin Knight and is headquartered in Sheffield, the United Kingdom.

MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom.

Oskare Capital SAS is an Independent firm. Oskare Capital SAS is headquartered in Paris, France.

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom.

Wobble Genomics Ltd. develops DNA normalization technology to maximize sampling efficiency during sequencing. The company is based in Edinburgh, UK.

Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell.

QUBIS Ltd (Qubis) is a venture capital firm, subsidiary of Queen's University of Belfast founded in the year 1984. The firm is headquartered in Belfast, Northern Ireland.

Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom.

Ten Bio Ltd. specializes in providing tailor-made solutions to help clients achieve progress in their skin research programs. The private company is based in Dundee, UK. The British company offers full-thickness human skin with dermal and epidermal layers, appendages, and minor skin cell populations. The company's human skin model, TenSkin™, responds like it would in vivo, delivering predictive results that contribute to a more efficient development process. The company was founded in 2019 by Robyn Hickerson and Michael Patrick Conneely, with Robyn Hickerson serving as CEO since then.